Login

The Director and Co-Head of UK Corporate Finance at Houlihan Lokey specializes in the food & beverage sector, offering expert advisory services. 00:10:00

Share On Facebook Share On Twitter

Scott Beiser is a Co-Chairman of Houlihan Lokey

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Leo Lithium Provides Update on Goulamina Project at Mining Conference
00:10:00
Tembo Capital's Investment Strategy in Junior to Intermediate Mining Companies
00:10:00
Advice for Entrepreneurs: Believe, Focus, and Stay Ahead in Innovation
00:10:00
Bank Stocks vs. Fintech Valuations
00:10:00
Marks Discusses Interest Rates and Credit Value on Bloomberg Wealth with David Rubenstein
00:10:00
Marco's Insights on the Booming Latino Economy and Investment Strategies
00:10:00
Archrock CEO talks about its role as a provider of outsourced natural gas compression in the U.S. | Bradley Childers, CEO, Archrock IncAROC:NYQ
00:10:00
Addressing Lead Ammunition Ban Concerns and Compliance Challenges
00:10:00
The EDV is proving safe and effective across a number of late-stage, intractable cancers like pancreatic cancer and mesothelioma| Dr Jennifer MacDiarmid , CEO OF ENGENEIC
00:10:00
Canyon Resources is confident in Minim Martap's bauxite resource's size and quality | MR JEAN-SEBASTIEN BOUTET, CHIEF EXECUTIVE OFFICER, CANYON RESOURCES LTD
00:10:00
Decades of Market Wisdom: Tangu Tan's Insights on Malaysia's Economic Landscape | Tan Teng Boo, CEO ,  Capital Dynamics.
00:10:00
CEO Perspectives: Navigating Fiscal Policy, Market Volatility, and Economic Growth | John Koudounis, CEO , Calamos Investments LLC.

© 2026 Nehu